Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 26, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- July 24, 2006: Transfer of 28,414 Ordinary Shares.
- July 25, 2006: Transfer of 171,859 Ordinary Shares.
These transactions were advised to the Company on July 26, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust where all employees or former employees are potential beneficiaries. Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the shares held by the GSK Trust in the same capacity as other employees.
Investor Verification Points
- Verify the total number of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 (200,273 shares total).
- Confirm the status of the GSK Trust as a discretionary trust for employees and former employees.
- Note that this filing does not impact the Company's financial statements directly but relates to equity ownership changes.